Xtant Medical Holdings (XTNT) Revenue (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Revenue data on file, last reported at $33.3 million in Q3 2025.

• Revenue for Q3 2025 came in at $33.3 million, up 19.04% year-over-year; the trailing twelve-month figure through Sep 2025 was $133.1 million (up 16.88% YoY), and the FY2024 annual result was $117.3 million, up 28.44% from the prior year.
• Revenue retreated to $33.3 million in Q3 2025 per XTNT's latest filing, from $35.4 million in the prior quarter.
• Over five years, Revenue peaked at $35.4 million in Q2 2025 and troughed at $12.5 million in Q1 2021.
• A 5-year average of $22.3 million and a median of $20.2 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2021 and 2023: Revenue slipped 15.35% in 2021, then soared 84.07% in 2023.
• A 5-year view of Revenue shows it stood at $14.0 million in 2021, then increased by 9.31% to $15.3 million in 2022, then surged by 84.07% to $28.1 million in 2023, then climbed by 12.11% to $31.5 million in 2024, then advanced by 5.53% to $33.3 million in 2025.
• Business Quant data shows XTNT's Revenue at $33.3 million in Q3 2025, $35.4 million in Q2 2025, and $32.9 million in Q1 2025.